LABCORP CLINICAL DEVELOPMENT
Actief
0435.753.395 - 1130 Brussel
People administring LABCORP CLINICAL DEVELOPMENT
| Name | Role / Mandate | Year |
|---|---|---|
| David De Schacht | Vertegenwoordiger | 2021, 2020, 2019, 2018, 2017 |
| Frederick Walter Wojtowicz | Bestuurder | 2017 |
| Glenn Andrew Eisenberg | Bestuurder | 2021, 2020, 2019, 2018 |
| Robert James Davie | Bestuurder | 2019, 2018, 2017 |
| Robert Pringle | Bestuurder | 2020 |
| Robert Pringle | Gedelegeerd bestuurder | 2021, 2019, 2018, 2017 |
Companies administring LABCORP CLINICAL DEVELOPMENT
| Name | Enterprise # | Role | Year |
|---|---|---|---|
| DSD Associates Audit & Advies BV | 0828.471.555 | Commissaris | 2021, 2020 |
Companies that are administered by LABCORP CLINICAL DEVELOPMENT
| Name | Enterprise # | Role | Year |
|---|---|---|---|
| No data available |
Companies holding participations in LABCORP CLINICAL DEVELOPMENT
| Participations in | Value | Amount | % Direct | % Indirect | Type |
|---|---|---|---|
| No data available |
LABCORP CLINICAL DEVELOPMENT has participations in
| Participations in | Value | Amount | % Direct | % Indirect | Type |
|---|---|---|---|
| No data available |